Cargando…
Kinetic studies of novel inhibitors of endomorphin degrading enzymes
Endomorphins (EMs), two endogenous μ-opioid receptor selective ligands, are attractive lead compounds for opioid-based pain management studies. However, these peptides are quickly degraded by peptidases, in particular by dipeptidylpeptidase IV (DPP IV) and aminopeptidase M (APM). Targeting enzymatic...
Autores principales: | Perlikowska, Renata, Fichna, Jakub, do-Rego, Jean Claude, Gach, Katarzyna, Janecka, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359464/ https://www.ncbi.nlm.nih.gov/pubmed/22707871 http://dx.doi.org/10.1007/s00044-011-9666-5 |
Ejemplares similares
-
The role of morphine in regulation of cancer cell growth
por: Gach, Katarzyna, et al.
Publicado: (2011) -
New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells
por: Długosz-Pokorska, Angelika, et al.
Publicado: (2023) -
Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice
por: Wang, Zi-long, et al.
Publicado: (2014) -
Developmental Potential for Endomorphin Opioidmimetic Drugs
por: Okada, Yoshio, et al.
Publicado: (2012) -
Inducible expression of endomorphins in murine dendritic cells★
por: Yang, Xiaohuai, et al.
Publicado: (2012)